Effect of advanced age on the development of complications from intravesical bacillus Calmette-Guérin therapy

Urologic Oncology: Seminars and Original Investigations

Volumn 26, Issue 2, 2008, Pages 137-140

  Heiner, Jared G ^a   Terris, Martha K ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

BCG; Complications; Transitional cell carcinoma

Indexed keywords

BCG VACCINE;

ADULT; AGE; AGED; ARTICLE; CHILL; CYSTALGIA; CYSTITIS; DEATH; DISEASE COURSE; DRUG EFFECT; DRUG WITHDRAWAL; EPIDIDYMITIS; FEVER; HUMAN; INCIDENCE; LIVER GRANULOMA; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATITIS; RISK FACTOR; SIDE EFFECT; SKIN ULCER; TRANSITIONAL CELL CARCINOMA; VASCULITIS;

ADJUVANTS, IMMUNOLOGIC; AGE FACTORS; AGED; AGED, 80 AND OVER; BCG VACCINE; CARCINOMA, TRANSITIONAL CELL; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; URINARY BLADDER NEOPLASMS;

EID: 39649103641     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urolonc.2007.04.005     Document Type: Article

References (18)

1. Bohle A., and Brandau S. Immune mechanisms in bacillus Calmette-Guerin immunotherapy for superficial bladder cancer. J Urol 170 (2003) 964-969
2. Lamm D.L. Management of bladder cancer. J Urol 171 (2004) 2482-2483
3. DeVeale B., Brummel T., and Seroude L. Immunity and aging: The enemy within?. Aging Cell 3 (2004) 195-208
4. Malkowicz S.B. Management of superficial bladder cancer. In: Walsh P.C., Retik A.B., Vaughan Jr. E.D., et al. (Eds). Campbell's Urology. 8th ed. (2002), W.B. Saunders Co, Philadelphia (PA) 2789-2792
5. Rischmann P., Desgrandchamps F., Malavaud B., et al. BCG intravesical instillations: recommendations for side-effects management. Eur Urol 37 Suppl (2000) 33-36
6. Huang T.C. Management of complications of bacillus Calmette-Guerin immunotherapy in the treatment of bladder cancer. Ann Pharmacother 34 (2000) 529-532
7. Rawls W.H., Lamm D.L., Lowe B.A., et al. Fatal sepsis following intravesical bacillus Calmette-Guerin administration for bladder cancer. J Urol 144 (1990) 1328-1330
8. Gonzalez J.A., Marcol B.R., and Wolf M.C. Complications of intravesical bacillus Calmette-Guerin: A case report. J Urol 148 (1992) 1892-1893
9. Marans H.Y., and Bekirov H.M. Granulomatous hepatitis following intravesical bacillus Calmette-Guerin therapy for bladder carcinoma. J Urol 137 (1987) 111-112
10. Leebeek F.W., Ouwendijk R.J., Kolk A.H., et al. Granulomatous hepatitis caused by bacillus Calmette-Guerin (BCG) infection after BCG bladder instillation. Gut 38 (1996) 616-618
11. Orikasa K., Namima T., Ota S., et al. Acute eosinophilic pneumonia associated with intravesical bacillus Calmette-Guerin therapy of carcinoma in situ of the bladder. Int J Urol 10 (2003) 622-624
12. Kanematsu A., Inoue T., Iwamura H., et al. Intravesical bacillus Calmette-Guerin instillation for patients over 80 years old. Hinyokika Kiyo 44 (1998) 253-257
13. Catalona W.J., Hudson M.A., Gillen D.P., et al. Risks and benefits of repeated courses of intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer. J Urol 137 (1987) 220-224
14. Griffiths T.R.L., Charlton M., Neal D.E., et al. Treatment of carcinoma in situ with intravesical bacillus Calmette-Guerin without maintenance. J Urol 167 (2002) 2408-2412
15. P'ng K.B., Walsh M.D., Seymour G.J., et al. The adverse effect of fibrin-clot inhibiting drugs on intravesical bacillus Calmette-Guerin efficacy for superficial bladder cancer. Aust N Z J Surg 63 (1993) 127-130
16. Hudson M.A., Brown E.J., Ritchey J.K., et al. Modulation of fibronectin-mediated Bacillus Calmette-Guerin attachment to murine bladder mucosa by drugs influencing the coagulation pathways. Cancer Res 51 (1991) 3726-3732
17. Hudson M.A., Yuan J.J., Catalona W.J., et al. Adverse impact of fibrin clot inhibitors on intravesical bacillus Calmette-Guerin therapy for superficial bladder tumors. J Urol 144 (1990) 1362-1364
18. Sylvester R.J., van der Meijden A.P., and Lamm D.L. Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: A meta-analysis of the published results of randomized clinical trials. J Urol 168 (2002) 1964-1970